Sinco Pharmaceuticals Holdings Limited Sinco Pharmaceuticals Holdings Limited

Sinco Pharmaceuticals Holdings Limited

6833

Rank in Stocks #24038
Sinco Pharmaceuticals Holdings Limited operates as an investment holding entity... Sinco Pharmaceuticals Holdings Limited operates as an investment holding entity primarily specializing in the marketing, promotion, and distribution channel management of imported pharmaceutical products and medical devices throughout China. Its product portfolio includes Octapharma, a human albumin solution specifically for premature infants; Axetine, prescribed for a range of bacterial infections such as respiratory, urinary tract, soft tissue, gynecological, obstetrical, and gonorrheal infections, and for post-surgical infection prevention; and Medocef, used to treat bacterial infections affecting the lower respiratory tract (including pneumonia), urinary tract, bile duct, peritoneum, skin, soft tissue, pelvic area, and conditions like sepsis. The company also supplies Esafosfina, effective in managing hypophosphatemia and chronic ailments like alcohol intoxication, malnutrition, and respiratory failure due to low phosphate levels. Additionally, it offers Taurolite, a third-generation oral cholic acid drug for gallstone diseases, and Tamifil injection, indicated for metastatic prostate cancer, true precocious puberty, and endometriosis. Beyond these core services, Sinco Pharmaceuticals also conducts sales of medicinal products, operates warehousing facilities for pharmaceuticals, provides international trade services, and offers consultation in medical and biological technology. Established in 2011, the company's headquarters are situated in Chengdu, People's Republic of China, and it operates as a subsidiary of Risun Investments Limited.
Share Price
$0.01682263
Last synced: 2026-11-17
Market Cap
$34.20M
Change (1 day)
1.52%
Change (1 year)
-29.21%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Sinco Pharmaceuticals Holdings Limited (6833)

Category

Healthcare
Operating Margin for Sinco Pharmaceuticals Holdings Limited (6833)
Operating Margin as of November 2026 TTM: 2.79%
According to Sinco Pharmaceuticals Holdings Limited's latest financial reports, its current operating margin (TTM) is 2.79%. At the end of 2025 the company had an operating margin of 3.45%.
Operating Margin history for Sinco Pharmaceuticals Holdings Limited from 2013 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 2.79% -19.13%
2025 3.45% 2.37%
2024 3.37% -20.89%
2023 4.26% 7.58%
2022 3.96% -51.82%
2021 8.22% 17.77%
2020 6.98% 41.01%
2019 4.95% -121.74%
2018 -22.77% 116.44%
2017 -10.52% -394.68%
2016 3.57% -63.20%
2015 9.70% -12.61%
2014 11.10% 20.92%
2013 9.18% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
1.62% -99.42%
US
1.30% -99.53%
US
1.05% -99.62%
US
1.16% -99.58%
US
9.21% -96.70%
AU
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Sinco Pharmaceuticals Holdings Limited's operating margin

What is Sinco Pharmaceuticals Holdings Limited's operating margin?

Sinco Pharmaceuticals Holdings Limited's operating margin is 2.79%, as of Nov 2026.

What was Sinco Pharmaceuticals Holdings Limited's operating margin in 2025?

In 2025, Sinco Pharmaceuticals Holdings Limited's operating margin was 3.45%, compared with 3.37% in 2024.

How has Sinco Pharmaceuticals Holdings Limited's operating margin changed since 2020?

From 2020 to 2025, Sinco Pharmaceuticals Holdings Limited's operating margin was highest in 2021 (8.22%) and lowest in 2024 (3.37%).

How does Sinco Pharmaceuticals Holdings Limited's operating margin compare with similar companies?

Sinco Pharmaceuticals Holdings Limited's operating margin (2.79%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Sigma Healthcare Limited, with 9.21%.